Soleno Therapeutics Inc (NASDAQ: SLNO): The Best-Of-Breed For Investing?
Currently, there are 48.53M common shares owned by the public and among those 41.69M shares have been available to trade. The company’s stock has a 5-day price change of 2.51% and 70.83% over the past three months. SLNO shares are trading 71.06% year to date (YTD), with the 12-month market performance up to 73.68% higher. […]